EP3492593
NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.11.2014EP published:
18.8.2021EP application number:
18214711.6
EPO information:
European Patent Register
Max expiry date:
12.11.2034
Title:
NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
Timeline
Today
13.11.2014EP application
18.8.2021EP Publication
Owner
Name:
Children's Medical Center CorporationAddress:
55 Shattuck Street, Boston, MA 02115, US
Name:
Sangamo Therapeutics, Inc.Address:
7000 Marina Blvd, Brisbane, CA 94005, US
Inventor
Name:
ORKIN, Stuart H.Address:
Boston, MA Massachusetts 02115, US
Name:
REIK, AndreasAddress:
Brisbane CA 94005, US
Name:
URNOV, FyodorAddress:
Brisbane CA 94005, US
Priority
Number:
201361903823 PDate:
13.11.2013Country:
US
Number:
201462042075 PDate:
26.8.2014Country:
US
Classification
Categories:
C12N 15/09, A61K 38/46, A61P 7/00, A61K 35/12, A61K 35/28, C07K 14/47, C12N 9/22, C12N 15/113